» Authors » Grzegorz Sobieszek

Grzegorz Sobieszek

Explore the profile of Grzegorz Sobieszek including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 101
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Szymczak A, Skwarek-Dziekanowska A, Sobieszek G, Malecka-Massalska T, Powrozek T
Int J Cardiol . 2025 Mar; :133165. PMID: 40088951
Background: Chronic heart failure (CHF) is a leading cause of hospitalization among the elderly in developed nations. CHF involves myocardial dysfunction and systemic disturbances, leading to high morbidity and mortality,...
2.
Powrozek T, Mazurek M, Kot A, Skwarek-Dziekanowska A, Sobieszek G, Malecka-Massalska T
J Nutr . 2025 Jan; 155(3):817-825. PMID: 39848496
Background: Systemic inflammation plays a crucial role in the development and progression of chronic heart failure (CHF) across all phenotypes. The continuous release of proinflammatory cytokines causes muscle atrophy and...
3.
Wanha W, Wolny R, Kleczynski P, Mattesini A, Iwanczyk S, Dziarmaga M, et al.
Kardiol Pol . 2025 Jan; 83(2):180-187. PMID: 39821623
Background: Intravascular lithotripsy (IVL) and excimer laser-coronary atherectomy (ELCA) could be both used in the percutaneous treatment of coronary stent underexpansion. Aims: To investigate the effectiveness and safety of IVL...
4.
Powrozek T, Skwarek-Dziekanowska A, Sobieszek G, Malecka-Massalska T
J Clin Med . 2024 Jan; 13(2). PMID: 38256568
Background: Neutrophil-to-lymphocyte ratio (NLR), platelets-to-lymphocyte ratio (PLR) and C-reactive protein-to-albumin ratio (CAR) are believed to be potential inflammatory markers that are closely related to the prognosis and course of cardiovascular...
5.
Sobieszek G, Zieba B, Dworzanski W, Celinski R, Barbero U, Opolski M
J Cardiovasc Dev Dis . 2023 Dec; 10(12). PMID: 38132663
Background: Iatrogenic distal coronary artery perforation can be a life-threatening complication. While there are different dedicated devices for the embolization of distal perforations, there are scarce data about the embolization...
6.
Opielak G, Powrozek T, Skwarek-Dziekanowska A, Sobieszek G, Kaminska K, Wojcik-Zaluska A, et al.
Postepy Kardiol Interwencyjnej . 2022 Aug; 18(1):34-42. PMID: 35982746
Introduction: To date, there are no literature reports of research investigating the relationship between depression and chronic heart failure (CHF) in relation to selected nutritional, cardiac and laboratory parameters. Aim:...
7.
Tyczynski P, Gasior M, Bujak K, Witkowski A, Pyka L, Gierlotka M, et al.
Kardiol Pol . 2022 Jul; 80(7-8):846-848. PMID: 35851464
No abstract available.
8.
Wanha W, Tomaniak M, Wanczura P, Bil J, Januszek R, Wolny R, et al.
J Clin Med . 2022 Apr; 11(7). PMID: 35407387
Background: Whereas the efficacy and safety of intravascular lithotripsy (IVL) have been confirmed in de novo calcified coronary lesions, little is known about its utility in treating stent underexpansion. This...
9.
Sobieszek G, Mlak R, Powrozek T, Mazurek M, Skwarek-Dziekanowska A, Terlecki P, et al.
Sci Rep . 2021 Oct; 11(1):20145. PMID: 34635743
Cardiac cachexia (CC) is an unfavorable metabolic syndrome leading to exacerbation of chronic heart failure (CHF) and a higher risk of death. The main factor contributing to the development of...
10.
Kubica J, Adamski P, Niezgoda P, Kubica A, Podhajski P, Baranska M, et al.
Cardiol J . 2021 Jun; 28(4):607-614. PMID: 34096012
The risk of ischemic events gradually decreases after acute coronary syndrome (ACS), reaching a stable level after 1 month, while the risk of bleeding remains steady during the whole period...